Quarterly report pursuant to Section 13 or 15(d)

Business Segment Information (Tables)

v3.24.1.u1
Business Segment Information (Tables)
3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The financial information summarized below is presented by reportable segment for the three months ended March 31, 2024 and 2023:
2024
(in thousands) Patient Services Device Solutions
Corporate/
Eliminations
Total
 
Net revenues - external $ 18,591 $ 13,404 $ — $ 31,995
Net revenues - internal — 1,713 (1,713) —
Total net revenues 18,591 15,117 (1,713) 31,995
Gross profit 12,274 4,200 — 16,474
Selling, general and administrative expenses 17,319
Interest expense (456)
Other income 3
Loss before income taxes $ (1,298)
Total assets $ 57,996 $ 44,854 $ 2,000 $ 104,850
Purchases of medical equipment $ 350 $ 1,143 $ — $ 1,493
Depreciation and amortization of intangible assets $ 1,856 $ 1,044 $ — $ 2,900
2023
(in thousands) Patient Services Device Solutions
Corporate/
Eliminations
Total
Net revenues - external $ 18,774 $ 11,596 $ — $ 30,370
Net revenues - internal — 1,630 (1,630) —
Total net revenues 18,774 13,226 (1,630) 30,370
Gross profit 11,541 3,409 — 14,950
Selling, general and administrative expenses 15,057
Interest expense (484)
Other expense (35)
Loss before income taxes $ (626)
Total assets $ 62,769 $ 37,492 $ 2,000 $ 102,261
Purchases of medical equipment $ 2,673 $ 1,295 $ — $ 3,968
Depreciation and amortization of intangible assets $ 2,178 $ 1,025 $ — $ 3,203